Advertisement

Index by author

September 01, 2018; Volume 46,Issue 9

A

  1. Ahn, Sojung

    1. Disposition of Methamphetamine and Major Metabolites in Mice: Role of Organic Cation Transporter 3 in Tissue-Selective Accumulation of Para-Hydroxymethamphetamine
      David J. Wagner, Laura M. Shireman, Sojung Ahn, Danny D. Shen and Joanne Wang
      Drug Metabolism and Disposition September 2018, 46 (9) 1277-1284; DOI: https://doi.org/10.1124/dmd.118.082131

B

  1. Bapiro, Tashinga E.

    1. Complete Substrate Inhibition of Cytochrome P450 2C8 by AZD9496, an Oral Selective Estrogen Receptor Degrader
      Tashinga E. Bapiro, Andy Sykes, Scott Martin, Michael Davies, James W. T. Yates, Matthias Hoch, Helen E. Rollison and Barry Jones
      Drug Metabolism and Disposition September 2018, 46 (9) 1268-1276; DOI: https://doi.org/10.1124/dmd.118.081539

  2. Baptista, Pedro Miguel

    1. Recellularized Native Kidney Scaffolds as a Novel Tool in Nephrotoxicity Screening
      Michele Fedecostante, Koen G. C. Westphal, Michele F. Buono, Natalia Sanchez Romero, Martijn J. Wilmer, Janis Kerkering, Pedro Miguel Baptista, Joost G. Hoenderop and Rosalinde Masereeuw
      Drug Metabolism and Disposition September 2018, 46 (9) 1338-1350; DOI: https://doi.org/10.1124/dmd.118.080721

  3. Buckley, David B.

    1. Open Access
      Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidances from Regulatory Agencies: Focus on CYP3A4 mRNA In Vitro Response Thresholds, Variability, and Clinical Relevance
      Jane R. Kenny, Diane Ramsden, David B. Buckley, Shannon Dallas, Conrad Fung, Michael Mohutsky, Heidi J. Einolf, Liangfu Chen, Joshua G. Dekeyser, Maria Fitzgerald, Theunis C. Goosen, Y. Amy Siu, Robert L. Walsky, George Zhang, Donald Tweedie and Niresh Hariparsad
      Drug Metabolism and Disposition September 2018, 46 (9) 1285-1303; DOI: https://doi.org/10.1124/dmd.118.081927

  4. Buono, Michele F.

    1. Recellularized Native Kidney Scaffolds as a Novel Tool in Nephrotoxicity Screening
      Michele Fedecostante, Koen G. C. Westphal, Michele F. Buono, Natalia Sanchez Romero, Martijn J. Wilmer, Janis Kerkering, Pedro Miguel Baptista, Joost G. Hoenderop and Rosalinde Masereeuw
      Drug Metabolism and Disposition September 2018, 46 (9) 1338-1350; DOI: https://doi.org/10.1124/dmd.118.080721

C

  1. Cao, Lijuan

    1. Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation
      Tingting Yan, Hong Wang, Lijuan Cao, Qiong Wang, Shogo Takahashi, Tomoki Yagai, Guolin Li, Kristopher W. Krausz, Guangji Wang, Frank J. Gonzalez and Haiping Hao
      Drug Metabolism and Disposition September 2018, 46 (9) 1310-1319; DOI: https://doi.org/10.1124/dmd.118.082008

  2. Chen, Liangfu

    1. Open Access
      Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidances from Regulatory Agencies: Focus on CYP3A4 mRNA In Vitro Response Thresholds, Variability, and Clinical Relevance
      Jane R. Kenny, Diane Ramsden, David B. Buckley, Shannon Dallas, Conrad Fung, Michael Mohutsky, Heidi J. Einolf, Liangfu Chen, Joshua G. Dekeyser, Maria Fitzgerald, Theunis C. Goosen, Y. Amy Siu, Robert L. Walsky, George Zhang, Donald Tweedie and Niresh Hariparsad
      Drug Metabolism and Disposition September 2018, 46 (9) 1285-1303; DOI: https://doi.org/10.1124/dmd.118.081927

  3. Chen, Xiaoyan

    1. Differences in the In Vivo and In Vitro Metabolism of Imrecoxib in Humans: Formation of the Rate-Limiting Aldehyde Intermediate
      Xiangyu Hou, Jialan Zhou, Songda Yu, Lei Zhou, Yifan Zhang, Dafang Zhong and Xiaoyan Chen
      Drug Metabolism and Disposition September 2018, 46 (9) 1320-1328; DOI: https://doi.org/10.1124/dmd.118.081182

  4. Colclough, Nicola

    1. An Investigation into the Prediction of the Plasma Concentration-Time Profile and Its Interindividual Variability for a Range of Flavin-Containing Monooxygenase Substrates Using a Physiologically Based Pharmacokinetic Modeling Approach
      Venkatesh Pilla Reddy, Barry C. Jones, Nicola Colclough, Abhishek Srivastava, Joanne Wilson and Danxi Li
      Drug Metabolism and Disposition September 2018, 46 (9) 1259-1267; DOI: https://doi.org/10.1124/dmd.118.080648

D

  1. Dallas, Shannon

    1. Open Access
      Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidances from Regulatory Agencies: Focus on CYP3A4 mRNA In Vitro Response Thresholds, Variability, and Clinical Relevance
      Jane R. Kenny, Diane Ramsden, David B. Buckley, Shannon Dallas, Conrad Fung, Michael Mohutsky, Heidi J. Einolf, Liangfu Chen, Joshua G. Dekeyser, Maria Fitzgerald, Theunis C. Goosen, Y. Amy Siu, Robert L. Walsky, George Zhang, Donald Tweedie and Niresh Hariparsad
      Drug Metabolism and Disposition September 2018, 46 (9) 1285-1303; DOI: https://doi.org/10.1124/dmd.118.081927

  2. Davies, Michael

    1. Complete Substrate Inhibition of Cytochrome P450 2C8 by AZD9496, an Oral Selective Estrogen Receptor Degrader
      Tashinga E. Bapiro, Andy Sykes, Scott Martin, Michael Davies, James W. T. Yates, Matthias Hoch, Helen E. Rollison and Barry Jones
      Drug Metabolism and Disposition September 2018, 46 (9) 1268-1276; DOI: https://doi.org/10.1124/dmd.118.081539

  3. Dekeyser, Joshua G.

    1. Open Access
      Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidances from Regulatory Agencies: Focus on CYP3A4 mRNA In Vitro Response Thresholds, Variability, and Clinical Relevance
      Jane R. Kenny, Diane Ramsden, David B. Buckley, Shannon Dallas, Conrad Fung, Michael Mohutsky, Heidi J. Einolf, Liangfu Chen, Joshua G. Dekeyser, Maria Fitzgerald, Theunis C. Goosen, Y. Amy Siu, Robert L. Walsky, George Zhang, Donald Tweedie and Niresh Hariparsad
      Drug Metabolism and Disposition September 2018, 46 (9) 1285-1303; DOI: https://doi.org/10.1124/dmd.118.081927

E

  1. Einolf, Heidi J.

    1. Open Access
      Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidances from Regulatory Agencies: Focus on CYP3A4 mRNA In Vitro Response Thresholds, Variability, and Clinical Relevance
      Jane R. Kenny, Diane Ramsden, David B. Buckley, Shannon Dallas, Conrad Fung, Michael Mohutsky, Heidi J. Einolf, Liangfu Chen, Joshua G. Dekeyser, Maria Fitzgerald, Theunis C. Goosen, Y. Amy Siu, Robert L. Walsky, George Zhang, Donald Tweedie and Niresh Hariparsad
      Drug Metabolism and Disposition September 2018, 46 (9) 1285-1303; DOI: https://doi.org/10.1124/dmd.118.081927

F

  1. Fang, Yan

    1. Content and Activities of UGT2B7 in Human Liver In Vitro and Predicted In Vivo: A Bottom-Up Approach
      Chen Xu, Jie Gao, Hai-Feng Zhang, Na Gao, Yuan-yuan Guo, Yan Fang, Qiang Wen and Hai-Ling Qiao
      Drug Metabolism and Disposition September 2018, 46 (9) 1351-1359; DOI: https://doi.org/10.1124/dmd.118.082024

  2. Fedecostante, Michele

    1. Recellularized Native Kidney Scaffolds as a Novel Tool in Nephrotoxicity Screening
      Michele Fedecostante, Koen G. C. Westphal, Michele F. Buono, Natalia Sanchez Romero, Martijn J. Wilmer, Janis Kerkering, Pedro Miguel Baptista, Joost G. Hoenderop and Rosalinde Masereeuw
      Drug Metabolism and Disposition September 2018, 46 (9) 1338-1350; DOI: https://doi.org/10.1124/dmd.118.080721

  3. Fitzgerald, Maria

    1. Open Access
      Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidances from Regulatory Agencies: Focus on CYP3A4 mRNA In Vitro Response Thresholds, Variability, and Clinical Relevance
      Jane R. Kenny, Diane Ramsden, David B. Buckley, Shannon Dallas, Conrad Fung, Michael Mohutsky, Heidi J. Einolf, Liangfu Chen, Joshua G. Dekeyser, Maria Fitzgerald, Theunis C. Goosen, Y. Amy Siu, Robert L. Walsky, George Zhang, Donald Tweedie and Niresh Hariparsad
      Drug Metabolism and Disposition September 2018, 46 (9) 1285-1303; DOI: https://doi.org/10.1124/dmd.118.081927

  4. Fung, Conrad

    1. Open Access
      Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidances from Regulatory Agencies: Focus on CYP3A4 mRNA In Vitro Response Thresholds, Variability, and Clinical Relevance
      Jane R. Kenny, Diane Ramsden, David B. Buckley, Shannon Dallas, Conrad Fung, Michael Mohutsky, Heidi J. Einolf, Liangfu Chen, Joshua G. Dekeyser, Maria Fitzgerald, Theunis C. Goosen, Y. Amy Siu, Robert L. Walsky, George Zhang, Donald Tweedie and Niresh Hariparsad
      Drug Metabolism and Disposition September 2018, 46 (9) 1285-1303; DOI: https://doi.org/10.1124/dmd.118.081927

G

  1. Gao, Jie

    1. Content and Activities of UGT2B7 in Human Liver In Vitro and Predicted In Vivo: A Bottom-Up Approach
      Chen Xu, Jie Gao, Hai-Feng Zhang, Na Gao, Yuan-yuan Guo, Yan Fang, Qiang Wen and Hai-Ling Qiao
      Drug Metabolism and Disposition September 2018, 46 (9) 1351-1359; DOI: https://doi.org/10.1124/dmd.118.082024

  2. Gao, Na

    1. Content and Activities of UGT2B7 in Human Liver In Vitro and Predicted In Vivo: A Bottom-Up Approach
      Chen Xu, Jie Gao, Hai-Feng Zhang, Na Gao, Yuan-yuan Guo, Yan Fang, Qiang Wen and Hai-Ling Qiao
      Drug Metabolism and Disposition September 2018, 46 (9) 1351-1359; DOI: https://doi.org/10.1124/dmd.118.082024

  3. Godamudunage, Malika P.

    1. Comparison of Antifungal Azole Interactions with Adult Cytochrome P450 3A4 versus Neonatal Cytochrome P450 3A7
      Malika P. Godamudunage, Anne M. Grech and Emily E. Scott
      Drug Metabolism and Disposition September 2018, 46 (9) 1329-1337; DOI: https://doi.org/10.1124/dmd.118.082032

  4. Gonzalez, Frank J.

    1. Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation
      Tingting Yan, Hong Wang, Lijuan Cao, Qiong Wang, Shogo Takahashi, Tomoki Yagai, Guolin Li, Kristopher W. Krausz, Guangji Wang, Frank J. Gonzalez and Haiping Hao
      Drug Metabolism and Disposition September 2018, 46 (9) 1310-1319; DOI: https://doi.org/10.1124/dmd.118.082008

  5. Goosen, Theunis C.

    1. Open Access
      Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidances from Regulatory Agencies: Focus on CYP3A4 mRNA In Vitro Response Thresholds, Variability, and Clinical Relevance
      Jane R. Kenny, Diane Ramsden, David B. Buckley, Shannon Dallas, Conrad Fung, Michael Mohutsky, Heidi J. Einolf, Liangfu Chen, Joshua G. Dekeyser, Maria Fitzgerald, Theunis C. Goosen, Y. Amy Siu, Robert L. Walsky, George Zhang, Donald Tweedie and Niresh Hariparsad
      Drug Metabolism and Disposition September 2018, 46 (9) 1285-1303; DOI: https://doi.org/10.1124/dmd.118.081927

  6. Grech, Anne M.

    1. Comparison of Antifungal Azole Interactions with Adult Cytochrome P450 3A4 versus Neonatal Cytochrome P450 3A7
      Malika P. Godamudunage, Anne M. Grech and Emily E. Scott
      Drug Metabolism and Disposition September 2018, 46 (9) 1329-1337; DOI: https://doi.org/10.1124/dmd.118.082032

  7. Guo, Yuan-yuan

    1. Content and Activities of UGT2B7 in Human Liver In Vitro and Predicted In Vivo: A Bottom-Up Approach
      Chen Xu, Jie Gao, Hai-Feng Zhang, Na Gao, Yuan-yuan Guo, Yan Fang, Qiang Wen and Hai-Ling Qiao
      Drug Metabolism and Disposition September 2018, 46 (9) 1351-1359; DOI: https://doi.org/10.1124/dmd.118.082024

H

  1. Hao, Haiping

    1. Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation
      Tingting Yan, Hong Wang, Lijuan Cao, Qiong Wang, Shogo Takahashi, Tomoki Yagai, Guolin Li, Kristopher W. Krausz, Guangji Wang, Frank J. Gonzalez and Haiping Hao
      Drug Metabolism and Disposition September 2018, 46 (9) 1310-1319; DOI: https://doi.org/10.1124/dmd.118.082008

  2. Hariparsad, Niresh

    1. Open Access
      Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidances from Regulatory Agencies: Focus on CYP3A4 mRNA In Vitro Response Thresholds, Variability, and Clinical Relevance
      Jane R. Kenny, Diane Ramsden, David B. Buckley, Shannon Dallas, Conrad Fung, Michael Mohutsky, Heidi J. Einolf, Liangfu Chen, Joshua G. Dekeyser, Maria Fitzgerald, Theunis C. Goosen, Y. Amy Siu, Robert L. Walsky, George Zhang, Donald Tweedie and Niresh Hariparsad
      Drug Metabolism and Disposition September 2018, 46 (9) 1285-1303; DOI: https://doi.org/10.1124/dmd.118.081927

  3. Hoch, Matthias

    1. Complete Substrate Inhibition of Cytochrome P450 2C8 by AZD9496, an Oral Selective Estrogen Receptor Degrader
      Tashinga E. Bapiro, Andy Sykes, Scott Martin, Michael Davies, James W. T. Yates, Matthias Hoch, Helen E. Rollison and Barry Jones
      Drug Metabolism and Disposition September 2018, 46 (9) 1268-1276; DOI: https://doi.org/10.1124/dmd.118.081539

  4. Hodge, Jessica

    1. The Roles of Xenobiotic Receptors: Beyond Chemical Disposition
      Bryan Mackowiak, Jessica Hodge, Sydney Stern and Hongbing Wang
      Drug Metabolism and Disposition September 2018, 46 (9) 1361-1371; DOI: https://doi.org/10.1124/dmd.118.081042

  5. Hoenderop, Joost G.

    1. Recellularized Native Kidney Scaffolds as a Novel Tool in Nephrotoxicity Screening
      Michele Fedecostante, Koen G. C. Westphal, Michele F. Buono, Natalia Sanchez Romero, Martijn J. Wilmer, Janis Kerkering, Pedro Miguel Baptista, Joost G. Hoenderop and Rosalinde Masereeuw
      Drug Metabolism and Disposition September 2018, 46 (9) 1338-1350; DOI: https://doi.org/10.1124/dmd.118.080721

  6. Hou, Xiangyu

    1. Differences in the In Vivo and In Vitro Metabolism of Imrecoxib in Humans: Formation of the Rate-Limiting Aldehyde Intermediate
      Xiangyu Hou, Jialan Zhou, Songda Yu, Lei Zhou, Yifan Zhang, Dafang Zhong and Xiaoyan Chen
      Drug Metabolism and Disposition September 2018, 46 (9) 1320-1328; DOI: https://doi.org/10.1124/dmd.118.081182

I

  1. Ishida, Kazuya

    1. Transport Kinetics, Selective Inhibition, and Successful Prediction of In Vivo Inhibition of Rat Hepatic Organic Anion Transporting Polypeptides
      Kazuya Ishida, Mohammed Ullah, Beáta Tóth, Viktoria Juhasz and Jashvant D. Unadkat
      Drug Metabolism and Disposition September 2018, 46 (9) 1251-1258; DOI: https://doi.org/10.1124/dmd.118.080770

J

  1. Johnson, Cassandra

    1. Decreased Kidney Function Is Associated with Enhanced Hepatic Flavin Monooxygenase Activity and Increased Circulating Trimethylamine N-Oxide Concentrations in Mice
      Cassandra Johnson, Alexander J. Prokopienko, Raymond E. West, Thomas D. Nolin and Jason R. Stubbs
      Drug Metabolism and Disposition September 2018, 46 (9) 1304-1309; DOI: https://doi.org/10.1124/dmd.118.081646

  2. Jones, Barry

    1. Complete Substrate Inhibition of Cytochrome P450 2C8 by AZD9496, an Oral Selective Estrogen Receptor Degrader
      Tashinga E. Bapiro, Andy Sykes, Scott Martin, Michael Davies, James W. T. Yates, Matthias Hoch, Helen E. Rollison and Barry Jones
      Drug Metabolism and Disposition September 2018, 46 (9) 1268-1276; DOI: https://doi.org/10.1124/dmd.118.081539

  3. Jones, Barry C.

    1. An Investigation into the Prediction of the Plasma Concentration-Time Profile and Its Interindividual Variability for a Range of Flavin-Containing Monooxygenase Substrates Using a Physiologically Based Pharmacokinetic Modeling Approach
      Venkatesh Pilla Reddy, Barry C. Jones, Nicola Colclough, Abhishek Srivastava, Joanne Wilson and Danxi Li
      Drug Metabolism and Disposition September 2018, 46 (9) 1259-1267; DOI: https://doi.org/10.1124/dmd.118.080648

  4. Juhasz, Viktoria

    1. Transport Kinetics, Selective Inhibition, and Successful Prediction of In Vivo Inhibition of Rat Hepatic Organic Anion Transporting Polypeptides
      Kazuya Ishida, Mohammed Ullah, Beáta Tóth, Viktoria Juhasz and Jashvant D. Unadkat
      Drug Metabolism and Disposition September 2018, 46 (9) 1251-1258; DOI: https://doi.org/10.1124/dmd.118.080770

K

  1. Kalari, Krishna R.

    1. Single Nucleotide Polymorphisms (SNPs) Distant from Xenobiotic Response Elements Can Modulate Aryl Hydrocarbon Receptor Function: SNP-Dependent CYP1A1 Induction
      Duan Liu, Sisi Qin, Balmiki Ray, Krishna R. Kalari, Liewei Wang and Richard M. Weinshilboum
      Drug Metabolism and Disposition September 2018, 46 (9) 1372-1381; DOI: https://doi.org/10.1124/dmd.118.082164

  2. Kenny, Jane R.

    1. Open Access
      Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidances from Regulatory Agencies: Focus on CYP3A4 mRNA In Vitro Response Thresholds, Variability, and Clinical Relevance
      Jane R. Kenny, Diane Ramsden, David B. Buckley, Shannon Dallas, Conrad Fung, Michael Mohutsky, Heidi J. Einolf, Liangfu Chen, Joshua G. Dekeyser, Maria Fitzgerald, Theunis C. Goosen, Y. Amy Siu, Robert L. Walsky, George Zhang, Donald Tweedie and Niresh Hariparsad
      Drug Metabolism and Disposition September 2018, 46 (9) 1285-1303; DOI: https://doi.org/10.1124/dmd.118.081927

  3. Kerkering, Janis

    1. Recellularized Native Kidney Scaffolds as a Novel Tool in Nephrotoxicity Screening
      Michele Fedecostante, Koen G. C. Westphal, Michele F. Buono, Natalia Sanchez Romero, Martijn J. Wilmer, Janis Kerkering, Pedro Miguel Baptista, Joost G. Hoenderop and Rosalinde Masereeuw
      Drug Metabolism and Disposition September 2018, 46 (9) 1338-1350; DOI: https://doi.org/10.1124/dmd.118.080721

  4. Krausz, Kristopher W.

    1. Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation
      Tingting Yan, Hong Wang, Lijuan Cao, Qiong Wang, Shogo Takahashi, Tomoki Yagai, Guolin Li, Kristopher W. Krausz, Guangji Wang, Frank J. Gonzalez and Haiping Hao
      Drug Metabolism and Disposition September 2018, 46 (9) 1310-1319; DOI: https://doi.org/10.1124/dmd.118.082008

L

  1. Li, Danxi

    1. An Investigation into the Prediction of the Plasma Concentration-Time Profile and Its Interindividual Variability for a Range of Flavin-Containing Monooxygenase Substrates Using a Physiologically Based Pharmacokinetic Modeling Approach
      Venkatesh Pilla Reddy, Barry C. Jones, Nicola Colclough, Abhishek Srivastava, Joanne Wilson and Danxi Li
      Drug Metabolism and Disposition September 2018, 46 (9) 1259-1267; DOI: https://doi.org/10.1124/dmd.118.080648

  2. Li, Guolin

    1. Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation
      Tingting Yan, Hong Wang, Lijuan Cao, Qiong Wang, Shogo Takahashi, Tomoki Yagai, Guolin Li, Kristopher W. Krausz, Guangji Wang, Frank J. Gonzalez and Haiping Hao
      Drug Metabolism and Disposition September 2018, 46 (9) 1310-1319; DOI: https://doi.org/10.1124/dmd.118.082008

  3. Liu, Duan

    1. Single Nucleotide Polymorphisms (SNPs) Distant from Xenobiotic Response Elements Can Modulate Aryl Hydrocarbon Receptor Function: SNP-Dependent CYP1A1 Induction
      Duan Liu, Sisi Qin, Balmiki Ray, Krishna R. Kalari, Liewei Wang and Richard M. Weinshilboum
      Drug Metabolism and Disposition September 2018, 46 (9) 1372-1381; DOI: https://doi.org/10.1124/dmd.118.082164

M

  1. Mackowiak, Bryan

    1. The Roles of Xenobiotic Receptors: Beyond Chemical Disposition
      Bryan Mackowiak, Jessica Hodge, Sydney Stern and Hongbing Wang
      Drug Metabolism and Disposition September 2018, 46 (9) 1361-1371; DOI: https://doi.org/10.1124/dmd.118.081042

  2. Martin, Scott

    1. Complete Substrate Inhibition of Cytochrome P450 2C8 by AZD9496, an Oral Selective Estrogen Receptor Degrader
      Tashinga E. Bapiro, Andy Sykes, Scott Martin, Michael Davies, James W. T. Yates, Matthias Hoch, Helen E. Rollison and Barry Jones
      Drug Metabolism and Disposition September 2018, 46 (9) 1268-1276; DOI: https://doi.org/10.1124/dmd.118.081539

  3. Masereeuw, Rosalinde

    1. Recellularized Native Kidney Scaffolds as a Novel Tool in Nephrotoxicity Screening
      Michele Fedecostante, Koen G. C. Westphal, Michele F. Buono, Natalia Sanchez Romero, Martijn J. Wilmer, Janis Kerkering, Pedro Miguel Baptista, Joost G. Hoenderop and Rosalinde Masereeuw
      Drug Metabolism and Disposition September 2018, 46 (9) 1338-1350; DOI: https://doi.org/10.1124/dmd.118.080721

  4. Mohutsky, Michael

    1. Open Access
      Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidances from Regulatory Agencies: Focus on CYP3A4 mRNA In Vitro Response Thresholds, Variability, and Clinical Relevance
      Jane R. Kenny, Diane Ramsden, David B. Buckley, Shannon Dallas, Conrad Fung, Michael Mohutsky, Heidi J. Einolf, Liangfu Chen, Joshua G. Dekeyser, Maria Fitzgerald, Theunis C. Goosen, Y. Amy Siu, Robert L. Walsky, George Zhang, Donald Tweedie and Niresh Hariparsad
      Drug Metabolism and Disposition September 2018, 46 (9) 1285-1303; DOI: https://doi.org/10.1124/dmd.118.081927

N

  1. Nolin, Thomas D.

    1. Decreased Kidney Function Is Associated with Enhanced Hepatic Flavin Monooxygenase Activity and Increased Circulating Trimethylamine N-Oxide Concentrations in Mice
      Cassandra Johnson, Alexander J. Prokopienko, Raymond E. West, Thomas D. Nolin and Jason R. Stubbs
      Drug Metabolism and Disposition September 2018, 46 (9) 1304-1309; DOI: https://doi.org/10.1124/dmd.118.081646

P

  1. Prokopienko, Alexander J.

    1. Decreased Kidney Function Is Associated with Enhanced Hepatic Flavin Monooxygenase Activity and Increased Circulating Trimethylamine N-Oxide Concentrations in Mice
      Cassandra Johnson, Alexander J. Prokopienko, Raymond E. West, Thomas D. Nolin and Jason R. Stubbs
      Drug Metabolism and Disposition September 2018, 46 (9) 1304-1309; DOI: https://doi.org/10.1124/dmd.118.081646

Q

  1. Qiao, Hai-Ling

    1. Content and Activities of UGT2B7 in Human Liver In Vitro and Predicted In Vivo: A Bottom-Up Approach
      Chen Xu, Jie Gao, Hai-Feng Zhang, Na Gao, Yuan-yuan Guo, Yan Fang, Qiang Wen and Hai-Ling Qiao
      Drug Metabolism and Disposition September 2018, 46 (9) 1351-1359; DOI: https://doi.org/10.1124/dmd.118.082024

  2. Qin, Sisi

    1. Single Nucleotide Polymorphisms (SNPs) Distant from Xenobiotic Response Elements Can Modulate Aryl Hydrocarbon Receptor Function: SNP-Dependent CYP1A1 Induction
      Duan Liu, Sisi Qin, Balmiki Ray, Krishna R. Kalari, Liewei Wang and Richard M. Weinshilboum
      Drug Metabolism and Disposition September 2018, 46 (9) 1372-1381; DOI: https://doi.org/10.1124/dmd.118.082164

R

  1. Ramsden, Diane

    1. Open Access
      Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidances from Regulatory Agencies: Focus on CYP3A4 mRNA In Vitro Response Thresholds, Variability, and Clinical Relevance
      Jane R. Kenny, Diane Ramsden, David B. Buckley, Shannon Dallas, Conrad Fung, Michael Mohutsky, Heidi J. Einolf, Liangfu Chen, Joshua G. Dekeyser, Maria Fitzgerald, Theunis C. Goosen, Y. Amy Siu, Robert L. Walsky, George Zhang, Donald Tweedie and Niresh Hariparsad
      Drug Metabolism and Disposition September 2018, 46 (9) 1285-1303; DOI: https://doi.org/10.1124/dmd.118.081927

  2. Ray, Balmiki

    1. Single Nucleotide Polymorphisms (SNPs) Distant from Xenobiotic Response Elements Can Modulate Aryl Hydrocarbon Receptor Function: SNP-Dependent CYP1A1 Induction
      Duan Liu, Sisi Qin, Balmiki Ray, Krishna R. Kalari, Liewei Wang and Richard M. Weinshilboum
      Drug Metabolism and Disposition September 2018, 46 (9) 1372-1381; DOI: https://doi.org/10.1124/dmd.118.082164

  3. Reddy, Venkatesh Pilla

    1. An Investigation into the Prediction of the Plasma Concentration-Time Profile and Its Interindividual Variability for a Range of Flavin-Containing Monooxygenase Substrates Using a Physiologically Based Pharmacokinetic Modeling Approach
      Venkatesh Pilla Reddy, Barry C. Jones, Nicola Colclough, Abhishek Srivastava, Joanne Wilson and Danxi Li
      Drug Metabolism and Disposition September 2018, 46 (9) 1259-1267; DOI: https://doi.org/10.1124/dmd.118.080648

  4. Rollison, Helen E.

    1. Complete Substrate Inhibition of Cytochrome P450 2C8 by AZD9496, an Oral Selective Estrogen Receptor Degrader
      Tashinga E. Bapiro, Andy Sykes, Scott Martin, Michael Davies, James W. T. Yates, Matthias Hoch, Helen E. Rollison and Barry Jones
      Drug Metabolism and Disposition September 2018, 46 (9) 1268-1276; DOI: https://doi.org/10.1124/dmd.118.081539

S

  1. Sanchez Romero, Natalia

    1. Recellularized Native Kidney Scaffolds as a Novel Tool in Nephrotoxicity Screening
      Michele Fedecostante, Koen G. C. Westphal, Michele F. Buono, Natalia Sanchez Romero, Martijn J. Wilmer, Janis Kerkering, Pedro Miguel Baptista, Joost G. Hoenderop and Rosalinde Masereeuw
      Drug Metabolism and Disposition September 2018, 46 (9) 1338-1350; DOI: https://doi.org/10.1124/dmd.118.080721

  2. Scott, Emily E.

    1. Comparison of Antifungal Azole Interactions with Adult Cytochrome P450 3A4 versus Neonatal Cytochrome P450 3A7
      Malika P. Godamudunage, Anne M. Grech and Emily E. Scott
      Drug Metabolism and Disposition September 2018, 46 (9) 1329-1337; DOI: https://doi.org/10.1124/dmd.118.082032

  3. Shen, Danny D.

    1. Disposition of Methamphetamine and Major Metabolites in Mice: Role of Organic Cation Transporter 3 in Tissue-Selective Accumulation of Para-Hydroxymethamphetamine
      David J. Wagner, Laura M. Shireman, Sojung Ahn, Danny D. Shen and Joanne Wang
      Drug Metabolism and Disposition September 2018, 46 (9) 1277-1284; DOI: https://doi.org/10.1124/dmd.118.082131

  4. Shireman, Laura M.

    1. Disposition of Methamphetamine and Major Metabolites in Mice: Role of Organic Cation Transporter 3 in Tissue-Selective Accumulation of Para-Hydroxymethamphetamine
      David J. Wagner, Laura M. Shireman, Sojung Ahn, Danny D. Shen and Joanne Wang
      Drug Metabolism and Disposition September 2018, 46 (9) 1277-1284; DOI: https://doi.org/10.1124/dmd.118.082131

  5. Siu, Y. Amy

    1. Open Access
      Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidances from Regulatory Agencies: Focus on CYP3A4 mRNA In Vitro Response Thresholds, Variability, and Clinical Relevance
      Jane R. Kenny, Diane Ramsden, David B. Buckley, Shannon Dallas, Conrad Fung, Michael Mohutsky, Heidi J. Einolf, Liangfu Chen, Joshua G. Dekeyser, Maria Fitzgerald, Theunis C. Goosen, Y. Amy Siu, Robert L. Walsky, George Zhang, Donald Tweedie and Niresh Hariparsad
      Drug Metabolism and Disposition September 2018, 46 (9) 1285-1303; DOI: https://doi.org/10.1124/dmd.118.081927

  6. Srivastava, Abhishek

    1. An Investigation into the Prediction of the Plasma Concentration-Time Profile and Its Interindividual Variability for a Range of Flavin-Containing Monooxygenase Substrates Using a Physiologically Based Pharmacokinetic Modeling Approach
      Venkatesh Pilla Reddy, Barry C. Jones, Nicola Colclough, Abhishek Srivastava, Joanne Wilson and Danxi Li
      Drug Metabolism and Disposition September 2018, 46 (9) 1259-1267; DOI: https://doi.org/10.1124/dmd.118.080648

  7. Stern, Sydney

    1. The Roles of Xenobiotic Receptors: Beyond Chemical Disposition
      Bryan Mackowiak, Jessica Hodge, Sydney Stern and Hongbing Wang
      Drug Metabolism and Disposition September 2018, 46 (9) 1361-1371; DOI: https://doi.org/10.1124/dmd.118.081042

  8. Stubbs, Jason R.

    1. Decreased Kidney Function Is Associated with Enhanced Hepatic Flavin Monooxygenase Activity and Increased Circulating Trimethylamine N-Oxide Concentrations in Mice
      Cassandra Johnson, Alexander J. Prokopienko, Raymond E. West, Thomas D. Nolin and Jason R. Stubbs
      Drug Metabolism and Disposition September 2018, 46 (9) 1304-1309; DOI: https://doi.org/10.1124/dmd.118.081646

  9. Sykes, Andy

    1. Complete Substrate Inhibition of Cytochrome P450 2C8 by AZD9496, an Oral Selective Estrogen Receptor Degrader
      Tashinga E. Bapiro, Andy Sykes, Scott Martin, Michael Davies, James W. T. Yates, Matthias Hoch, Helen E. Rollison and Barry Jones
      Drug Metabolism and Disposition September 2018, 46 (9) 1268-1276; DOI: https://doi.org/10.1124/dmd.118.081539

T

  1. Takahashi, Shogo

    1. Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation
      Tingting Yan, Hong Wang, Lijuan Cao, Qiong Wang, Shogo Takahashi, Tomoki Yagai, Guolin Li, Kristopher W. Krausz, Guangji Wang, Frank J. Gonzalez and Haiping Hao
      Drug Metabolism and Disposition September 2018, 46 (9) 1310-1319; DOI: https://doi.org/10.1124/dmd.118.082008

  2. Tóth, Beáta

    1. Transport Kinetics, Selective Inhibition, and Successful Prediction of In Vivo Inhibition of Rat Hepatic Organic Anion Transporting Polypeptides
      Kazuya Ishida, Mohammed Ullah, Beáta Tóth, Viktoria Juhasz and Jashvant D. Unadkat
      Drug Metabolism and Disposition September 2018, 46 (9) 1251-1258; DOI: https://doi.org/10.1124/dmd.118.080770

  3. Tweedie, Donald

    1. Open Access
      Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidances from Regulatory Agencies: Focus on CYP3A4 mRNA In Vitro Response Thresholds, Variability, and Clinical Relevance
      Jane R. Kenny, Diane Ramsden, David B. Buckley, Shannon Dallas, Conrad Fung, Michael Mohutsky, Heidi J. Einolf, Liangfu Chen, Joshua G. Dekeyser, Maria Fitzgerald, Theunis C. Goosen, Y. Amy Siu, Robert L. Walsky, George Zhang, Donald Tweedie and Niresh Hariparsad
      Drug Metabolism and Disposition September 2018, 46 (9) 1285-1303; DOI: https://doi.org/10.1124/dmd.118.081927

U

  1. Ullah, Mohammed

    1. Transport Kinetics, Selective Inhibition, and Successful Prediction of In Vivo Inhibition of Rat Hepatic Organic Anion Transporting Polypeptides
      Kazuya Ishida, Mohammed Ullah, Beáta Tóth, Viktoria Juhasz and Jashvant D. Unadkat
      Drug Metabolism and Disposition September 2018, 46 (9) 1251-1258; DOI: https://doi.org/10.1124/dmd.118.080770

  2. Unadkat, Jashvant D.

    1. Transport Kinetics, Selective Inhibition, and Successful Prediction of In Vivo Inhibition of Rat Hepatic Organic Anion Transporting Polypeptides
      Kazuya Ishida, Mohammed Ullah, Beáta Tóth, Viktoria Juhasz and Jashvant D. Unadkat
      Drug Metabolism and Disposition September 2018, 46 (9) 1251-1258; DOI: https://doi.org/10.1124/dmd.118.080770

W

  1. Wagner, David J.

    1. Disposition of Methamphetamine and Major Metabolites in Mice: Role of Organic Cation Transporter 3 in Tissue-Selective Accumulation of Para-Hydroxymethamphetamine
      David J. Wagner, Laura M. Shireman, Sojung Ahn, Danny D. Shen and Joanne Wang
      Drug Metabolism and Disposition September 2018, 46 (9) 1277-1284; DOI: https://doi.org/10.1124/dmd.118.082131

  2. Walsky, Robert L.

    1. Open Access
      Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidances from Regulatory Agencies: Focus on CYP3A4 mRNA In Vitro Response Thresholds, Variability, and Clinical Relevance
      Jane R. Kenny, Diane Ramsden, David B. Buckley, Shannon Dallas, Conrad Fung, Michael Mohutsky, Heidi J. Einolf, Liangfu Chen, Joshua G. Dekeyser, Maria Fitzgerald, Theunis C. Goosen, Y. Amy Siu, Robert L. Walsky, George Zhang, Donald Tweedie and Niresh Hariparsad
      Drug Metabolism and Disposition September 2018, 46 (9) 1285-1303; DOI: https://doi.org/10.1124/dmd.118.081927

  3. Wang, Guangji

    1. Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation
      Tingting Yan, Hong Wang, Lijuan Cao, Qiong Wang, Shogo Takahashi, Tomoki Yagai, Guolin Li, Kristopher W. Krausz, Guangji Wang, Frank J. Gonzalez and Haiping Hao
      Drug Metabolism and Disposition September 2018, 46 (9) 1310-1319; DOI: https://doi.org/10.1124/dmd.118.082008

  4. Wang, Hong

    1. Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation
      Tingting Yan, Hong Wang, Lijuan Cao, Qiong Wang, Shogo Takahashi, Tomoki Yagai, Guolin Li, Kristopher W. Krausz, Guangji Wang, Frank J. Gonzalez and Haiping Hao
      Drug Metabolism and Disposition September 2018, 46 (9) 1310-1319; DOI: https://doi.org/10.1124/dmd.118.082008

  5. Wang, Hongbing

    1. The Roles of Xenobiotic Receptors: Beyond Chemical Disposition
      Bryan Mackowiak, Jessica Hodge, Sydney Stern and Hongbing Wang
      Drug Metabolism and Disposition September 2018, 46 (9) 1361-1371; DOI: https://doi.org/10.1124/dmd.118.081042

  6. Wang, Joanne

    1. Disposition of Methamphetamine and Major Metabolites in Mice: Role of Organic Cation Transporter 3 in Tissue-Selective Accumulation of Para-Hydroxymethamphetamine
      David J. Wagner, Laura M. Shireman, Sojung Ahn, Danny D. Shen and Joanne Wang
      Drug Metabolism and Disposition September 2018, 46 (9) 1277-1284; DOI: https://doi.org/10.1124/dmd.118.082131

  7. Wang, Liewei

    1. Single Nucleotide Polymorphisms (SNPs) Distant from Xenobiotic Response Elements Can Modulate Aryl Hydrocarbon Receptor Function: SNP-Dependent CYP1A1 Induction
      Duan Liu, Sisi Qin, Balmiki Ray, Krishna R. Kalari, Liewei Wang and Richard M. Weinshilboum
      Drug Metabolism and Disposition September 2018, 46 (9) 1372-1381; DOI: https://doi.org/10.1124/dmd.118.082164

  8. Wang, Qiong

    1. Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation
      Tingting Yan, Hong Wang, Lijuan Cao, Qiong Wang, Shogo Takahashi, Tomoki Yagai, Guolin Li, Kristopher W. Krausz, Guangji Wang, Frank J. Gonzalez and Haiping Hao
      Drug Metabolism and Disposition September 2018, 46 (9) 1310-1319; DOI: https://doi.org/10.1124/dmd.118.082008

  9. Weinshilboum, Richard M.

    1. Single Nucleotide Polymorphisms (SNPs) Distant from Xenobiotic Response Elements Can Modulate Aryl Hydrocarbon Receptor Function: SNP-Dependent CYP1A1 Induction
      Duan Liu, Sisi Qin, Balmiki Ray, Krishna R. Kalari, Liewei Wang and Richard M. Weinshilboum
      Drug Metabolism and Disposition September 2018, 46 (9) 1372-1381; DOI: https://doi.org/10.1124/dmd.118.082164

  10. Wen, Qiang

    1. Content and Activities of UGT2B7 in Human Liver In Vitro and Predicted In Vivo: A Bottom-Up Approach
      Chen Xu, Jie Gao, Hai-Feng Zhang, Na Gao, Yuan-yuan Guo, Yan Fang, Qiang Wen and Hai-Ling Qiao
      Drug Metabolism and Disposition September 2018, 46 (9) 1351-1359; DOI: https://doi.org/10.1124/dmd.118.082024

  11. West, Raymond E.

    1. Decreased Kidney Function Is Associated with Enhanced Hepatic Flavin Monooxygenase Activity and Increased Circulating Trimethylamine N-Oxide Concentrations in Mice
      Cassandra Johnson, Alexander J. Prokopienko, Raymond E. West, Thomas D. Nolin and Jason R. Stubbs
      Drug Metabolism and Disposition September 2018, 46 (9) 1304-1309; DOI: https://doi.org/10.1124/dmd.118.081646

  12. Westphal, Koen G. C.

    1. Recellularized Native Kidney Scaffolds as a Novel Tool in Nephrotoxicity Screening
      Michele Fedecostante, Koen G. C. Westphal, Michele F. Buono, Natalia Sanchez Romero, Martijn J. Wilmer, Janis Kerkering, Pedro Miguel Baptista, Joost G. Hoenderop and Rosalinde Masereeuw
      Drug Metabolism and Disposition September 2018, 46 (9) 1338-1350; DOI: https://doi.org/10.1124/dmd.118.080721

  13. Wilmer, Martijn J.

    1. Recellularized Native Kidney Scaffolds as a Novel Tool in Nephrotoxicity Screening
      Michele Fedecostante, Koen G. C. Westphal, Michele F. Buono, Natalia Sanchez Romero, Martijn J. Wilmer, Janis Kerkering, Pedro Miguel Baptista, Joost G. Hoenderop and Rosalinde Masereeuw
      Drug Metabolism and Disposition September 2018, 46 (9) 1338-1350; DOI: https://doi.org/10.1124/dmd.118.080721

  14. Wilson, Joanne

    1. An Investigation into the Prediction of the Plasma Concentration-Time Profile and Its Interindividual Variability for a Range of Flavin-Containing Monooxygenase Substrates Using a Physiologically Based Pharmacokinetic Modeling Approach
      Venkatesh Pilla Reddy, Barry C. Jones, Nicola Colclough, Abhishek Srivastava, Joanne Wilson and Danxi Li
      Drug Metabolism and Disposition September 2018, 46 (9) 1259-1267; DOI: https://doi.org/10.1124/dmd.118.080648

X

  1. Xu, Chen

    1. Content and Activities of UGT2B7 in Human Liver In Vitro and Predicted In Vivo: A Bottom-Up Approach
      Chen Xu, Jie Gao, Hai-Feng Zhang, Na Gao, Yuan-yuan Guo, Yan Fang, Qiang Wen and Hai-Ling Qiao
      Drug Metabolism and Disposition September 2018, 46 (9) 1351-1359; DOI: https://doi.org/10.1124/dmd.118.082024

Y

  1. Yagai, Tomoki

    1. Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation
      Tingting Yan, Hong Wang, Lijuan Cao, Qiong Wang, Shogo Takahashi, Tomoki Yagai, Guolin Li, Kristopher W. Krausz, Guangji Wang, Frank J. Gonzalez and Haiping Hao
      Drug Metabolism and Disposition September 2018, 46 (9) 1310-1319; DOI: https://doi.org/10.1124/dmd.118.082008

  2. Yan, Tingting

    1. Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation
      Tingting Yan, Hong Wang, Lijuan Cao, Qiong Wang, Shogo Takahashi, Tomoki Yagai, Guolin Li, Kristopher W. Krausz, Guangji Wang, Frank J. Gonzalez and Haiping Hao
      Drug Metabolism and Disposition September 2018, 46 (9) 1310-1319; DOI: https://doi.org/10.1124/dmd.118.082008

  3. Yates, James W. T.

    1. Complete Substrate Inhibition of Cytochrome P450 2C8 by AZD9496, an Oral Selective Estrogen Receptor Degrader
      Tashinga E. Bapiro, Andy Sykes, Scott Martin, Michael Davies, James W. T. Yates, Matthias Hoch, Helen E. Rollison and Barry Jones
      Drug Metabolism and Disposition September 2018, 46 (9) 1268-1276; DOI: https://doi.org/10.1124/dmd.118.081539

  4. Yu, Songda

    1. Differences in the In Vivo and In Vitro Metabolism of Imrecoxib in Humans: Formation of the Rate-Limiting Aldehyde Intermediate
      Xiangyu Hou, Jialan Zhou, Songda Yu, Lei Zhou, Yifan Zhang, Dafang Zhong and Xiaoyan Chen
      Drug Metabolism and Disposition September 2018, 46 (9) 1320-1328; DOI: https://doi.org/10.1124/dmd.118.081182

Z

  1. Zhang, George

    1. Open Access
      Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidances from Regulatory Agencies: Focus on CYP3A4 mRNA In Vitro Response Thresholds, Variability, and Clinical Relevance
      Jane R. Kenny, Diane Ramsden, David B. Buckley, Shannon Dallas, Conrad Fung, Michael Mohutsky, Heidi J. Einolf, Liangfu Chen, Joshua G. Dekeyser, Maria Fitzgerald, Theunis C. Goosen, Y. Amy Siu, Robert L. Walsky, George Zhang, Donald Tweedie and Niresh Hariparsad
      Drug Metabolism and Disposition September 2018, 46 (9) 1285-1303; DOI: https://doi.org/10.1124/dmd.118.081927

  2. Zhang, Hai-Feng

    1. Content and Activities of UGT2B7 in Human Liver In Vitro and Predicted In Vivo: A Bottom-Up Approach
      Chen Xu, Jie Gao, Hai-Feng Zhang, Na Gao, Yuan-yuan Guo, Yan Fang, Qiang Wen and Hai-Ling Qiao
      Drug Metabolism and Disposition September 2018, 46 (9) 1351-1359; DOI: https://doi.org/10.1124/dmd.118.082024

  3. Zhang, Yifan

    1. Differences in the In Vivo and In Vitro Metabolism of Imrecoxib in Humans: Formation of the Rate-Limiting Aldehyde Intermediate
      Xiangyu Hou, Jialan Zhou, Songda Yu, Lei Zhou, Yifan Zhang, Dafang Zhong and Xiaoyan Chen
      Drug Metabolism and Disposition September 2018, 46 (9) 1320-1328; DOI: https://doi.org/10.1124/dmd.118.081182

  4. Zhong, Dafang

    1. Differences in the In Vivo and In Vitro Metabolism of Imrecoxib in Humans: Formation of the Rate-Limiting Aldehyde Intermediate
      Xiangyu Hou, Jialan Zhou, Songda Yu, Lei Zhou, Yifan Zhang, Dafang Zhong and Xiaoyan Chen
      Drug Metabolism and Disposition September 2018, 46 (9) 1320-1328; DOI: https://doi.org/10.1124/dmd.118.081182

  5. Zhou, Jialan

    1. Differences in the In Vivo and In Vitro Metabolism of Imrecoxib in Humans: Formation of the Rate-Limiting Aldehyde Intermediate
      Xiangyu Hou, Jialan Zhou, Songda Yu, Lei Zhou, Yifan Zhang, Dafang Zhong and Xiaoyan Chen
      Drug Metabolism and Disposition September 2018, 46 (9) 1320-1328; DOI: https://doi.org/10.1124/dmd.118.081182

  6. Zhou, Lei

    1. Differences in the In Vivo and In Vitro Metabolism of Imrecoxib in Humans: Formation of the Rate-Limiting Aldehyde Intermediate
      Xiangyu Hou, Jialan Zhou, Songda Yu, Lei Zhou, Yifan Zhang, Dafang Zhong and Xiaoyan Chen
      Drug Metabolism and Disposition September 2018, 46 (9) 1320-1328; DOI: https://doi.org/10.1124/dmd.118.081182
Back to top

In this issue

Advertisement